Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -4.86% | -10.16% | -2.14% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.65M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-1.41
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.17% |
Latest transcript on Artelo Biosciences, Inc.
1 day | -4.86% | ||
1 week | -10.16% | ||
Current month | -0.40% | ||
1 month | +2.25% | ||
3 months | -11.61% | ||
6 months | +11.38% | ||
Current year | -2.14% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Gorgas
CEO | Chief Executive Officer | 61 | 17-04-02 |
Andy Yates
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 17-05-01 |
Steven Kelly
BRD | Director/Board Member | 59 | 17-05-01 |
Gregory Reyes
BRD | Director/Board Member | 70 | 20-11-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 1.37 | -4.86% | 16,821 |
24-05-24 | 1.44 | -4.64% | 6,269 |
24-05-23 | 1.51 | -0.98% | 41,463 |
24-05-22 | 1.525 | 0.00% | 9,095 |
24-05-21 | 1.525 | -0.97% | 15,149 |
Delayed Quote Nasdaq, May 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.14% | 4.65M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- ARTL Stock